Sauri Gudlavalleti is the new Chief Operating Officer of Sai Life Sciences
He holds nine US patents and has published in multiple peer-reviewed journals and conferences
He holds nine US patents and has published in multiple peer-reviewed journals and conferences
Krivida Novus can detect the Omicron variant and its sub-lineages in 45 minutes
It provides Covid-19 detection and Omicron surveillance in less than two hours
New capabilities on Philips Image Guided therapy mobile C-arm system – Zenition – and collaboration with Cydar offer the latest advances in endovascular treatment
Prof Karikó's research was most notably used by Pfizer/BioNTech and Moderna to build COVID-19 mRNA vaccines
The drug is aimed at treating Covid-19 patients with Acute Respiratory Distress Syndrome (ARDS)
The company has 47 ANDA's pending approval with the U.S.FDA
The global multi-center phase-II clinical trial will be a 36-week, multi-center, randomized, double-blind, placebo-controlled trial, followed by a 36-week open-label extension period
The new collaboration focuses on a class of proteins called transcription factors, which control gene expression and can regulate important cellular processes including cell growth and survival
Chicago based virtual reality company reaches AIIMS, assisting in surgical planning and training
Subscribe To Our Newsletter & Stay Updated